EUVIMEDEUVIMED entdecken
Crossref

Digital Therapeutics in Type 2 Diabetes: Transforming Self-Management Through Technology-Driven Care

Alshada Sharf, R. Divyadharshini, S. Gopal, V. Gowrishankar, P. Hemavathi, U. Suriya

International Journal of Innovative Science and Research Technology · 10.03.2026 · 3051

DOI: 10.38124/ijisrt/26feb1254 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Innovative Science and Research Technology, online erschienen am 10.03.2026. Verfasst von Alshada Sharf und 5 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Particularly in primary care settings, digital health interventions have shown promise in enhancing medication adherence in patients with Type 2 Diabetes Mellitus (T2DM). A highly customized text and voice messaging intervention was assessed in a feasibility randomized controlled trial carried out in the UK to help patients with hypertension and/or type 2 diabetes take their medications as directed. Based on each person's beliefs, obstacles, and clinical traits, the intervention provided tailored behavioral support messages. Results showed that this type of customized digital communication is doable, patient-acceptable, and could enhance medication compliance and associated clinical outcomes in the treatment of chronic illnesses. The study also shown how individuals with type 2 diabetes can improve their self-management practices by incorporating theory-based behavioral approaches into mHealth platforms. When compared to conventional treatment, participants who received the intervention demonstrated increased engagement and good trends in adherence, suggesting that scalable digital messaging systems could improve long-term disease control. The study backs up the expanding importance of digital health technologies in routine primary care practice to enhance adherence and optimize outcomes for people with Type 2 Diabetes.

Zitieren

APA

Sharf, A., Divyadharshini, R., Gopal, S., Gowrishankar, V., Hemavathi, P., & Suriya, U. (2026). Digital Therapeutics in Type 2 Diabetes: Transforming Self-Management Through Technology-Driven Care. International Journal of Innovative Science and Research Technology, 3051. https://doi.org/10.38124/ijisrt/26feb1254

Vancouver

Sharf A, Divyadharshini R, Gopal S, Gowrishankar V, Hemavathi P, Suriya U. Digital Therapeutics in Type 2 Diabetes: Transforming Self-Management Through Technology-Driven Care. International Journal of Innovative Science and Research Technology. 2026:3051. doi:10.38124/ijisrt/26feb1254

BibTeX
@article{Sharf2026,
  author = {Sharf, Alshada and Divyadharshini, R. and Gopal, S. and Gowrishankar, V. and Hemavathi, P. and Suriya, U.},
  title = {Digital Therapeutics in Type 2 Diabetes: Transforming Self-Management Through Technology-Driven Care},
  journal = {International Journal of Innovative Science and Research Technology},
  year = {2026},
  pages = {3051},
  doi = {10.38124/ijisrt/26feb1254}
}
Kostenlos starten →